Literature DB >> 23007438

Non-compartmental analysis.

Johan Gabrielsson1, Daniel Weiner.   

Abstract

When analyzing pharmacokinetic data, one generally employs either model fitting using nonlinear regression analysis or non-compartmental analysis techniques (NCA). The method one actually employs depends on what is required from the analysis. If the primary requirement is to determine the degree of exposure following administration of a drug (such as AUC), and perhaps the drug's associated pharmacokinetic parameters, such as clearance, elimination half-life, T (max), C (max), etc., then NCA is generally the preferred methodology to use in that it requires fewer assumptions than model-based approaches. In this chapter we cover NCA methodologies, which utilize application of the trapezoidal rule for measurements of the area under the plasma concentration-time curve. This method, which generally applies to first-order (linear) models (although it is often used to assess if a drug's pharmacokinetics are nonlinear when several dose levels are administered), has few underlying assumptions and can readily be automated.In addition, because sparse data sampling methods are often utilized in toxicokinetic (TK) studies, NCA methodology appropriate for sparse data is also discussed.

Entities:  

Mesh:

Year:  2012        PMID: 23007438     DOI: 10.1007/978-1-62703-050-2_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  52 in total

1.  Population Pharmacokinetics of Vixotrigine in Healthy Volunteers and Subjects with Trigeminal Neuralgia, Painful Lumbosacral Radiculopathy and Erythromelalgia.

Authors:  Himanshu Naik; Yuan Zhao; Fiona Forrestal; Simon Cleall; Howard Bockbrader; Sunny Chapel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-05       Impact factor: 2.441

2.  Pharmacokinetics and Dosing of Levofloxacin in Children Treated for Active or Latent Multidrug-resistant Tuberculosis, Federated States of Micronesia and Republic of the Marshall Islands.

Authors:  Sundari R Mase; John A Jereb; Daniel Gonzalez; Fatma Martin; Charles L Daley; Dorina Fred; Ann M Loeffler; Lakshmy R Menon; Sapna Bamrah Morris; Richard Brostrom; Terence Chorba; Charles A Peloquin
Journal:  Pediatr Infect Dis J       Date:  2016-04       Impact factor: 2.129

3.  Comparative Pharmacokinetics of Δ9-Tetrahydrocannabinol in Adolescent and Adult Male Mice.

Authors:  Alexa Torrens; Valentina Vozella; Hannah Huff; Brandon McNeil; Faizy Ahmed; Andrea Ghidini; Stephen V Mahler; Marilyn A Huestis; Aditi Das; Daniele Piomelli
Journal:  J Pharmacol Exp Ther       Date:  2020-04-28       Impact factor: 4.030

4.  Dihydro-stilbene gigantol relieves CCl4-induced hepatic oxidative stress and inflammation in mice via inhibiting C5b-9 formation in the liver.

Authors:  Ya-Ru Xue; Sheng Yao; Qian Liu; Zhao-Liang Peng; Qiang-Qiang Deng; Bo Liu; Zheng-Hua Ma; Le Wang; Hu Zhou; Yang Ye; Guo-Yu Pan
Journal:  Acta Pharmacol Sin       Date:  2020-05-13       Impact factor: 6.150

5.  A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia.

Authors:  Keith W Pratz; Michelle A Rudek; Ivana Gojo; Mark R Litzow; Michael A McDevitt; Jiuping Ji; Larry M Karnitz; James G Herman; Robert J Kinders; B Douglas Smith; Steven D Gore; Hetty E Carraway; Margaret M Showel; Douglas E Gladstone; Mark J Levis; Hua-Ling Tsai; Gary Rosner; Alice Chen; Scott H Kaufmann; Judith E Karp
Journal:  Clin Cancer Res       Date:  2016-08-22       Impact factor: 12.531

6.  Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo.

Authors:  Denise Garcia; Patrick Nasarre; Ingrid V Bonilla; Eleanor Hilliard; Yuri K Peterson; Laura Spruill; Anne-Marie Broome; Elizabeth G Hill; Jason T Yustein; Shikhar Mehrotra; Nancy Klauber-DeMore
Journal:  Ann Surg Oncol       Date:  2019-09-12       Impact factor: 5.344

7.  Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquat.

Authors:  Sarah E Lacher; Julia N Gremaud; Kasse Skagen; Emily Steed; Rachel Dalton; Kent D Sugden; Fernando Cardozo-Pelaez; Catherine M T Sherwin; Erica L Woodahl
Journal:  J Pharmacol Exp Ther       Date:  2013-12-02       Impact factor: 4.030

8.  Toxicokinetics of the neonicotinoid insecticide imidacloprid in rainbow trout (Oncorhynchus mykiss).

Authors:  John A Frew; Jacob T Brown; Patrick N Fitzsimmons; Alex D Hoffman; Martin Sadilek; Christian E Grue; John W Nichols
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2018-02-03       Impact factor: 3.228

9.  Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.

Authors:  Tomoko Ichiki; Brenda K Huntley; S Jeson Sangaralingham; John C Burnett
Journal:  JACC Heart Fail       Date:  2015-09       Impact factor: 12.035

10.  PK-DB: pharmacokinetics database for individualized and stratified computational modeling.

Authors:  Jan Grzegorzewski; Janosch Brandhorst; Kathleen Green; Dimitra Eleftheriadou; Yannick Duport; Florian Barthorscht; Adrian Köller; Danny Yu Jia Ke; Sara De Angelis; Matthias König
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.